Timo Joensuu

2.4k total citations
27 papers, 893 citations indexed

About

Timo Joensuu is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Timo Joensuu has authored 27 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 24 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Timo Joensuu's work include Virus-based gene therapy research (25 papers), CAR-T cell therapy research (23 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Timo Joensuu is often cited by papers focused on Virus-based gene therapy research (25 papers), CAR-T cell therapy research (23 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Timo Joensuu collaborates with scholars based in Finland, Germany and United Kingdom. Timo Joensuu's co-authors include Akseli Hemminki, Anna Kanerva, Minna Oksanen, Anniina Koski, Ilkka Liikanen, Otto Hemminki, Vincenzo Cerullo, Kaarina Partanen, Lotta Kangasniemi and Saila K. Pesonen and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Timo Joensuu

24 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timo Joensuu Finland	18	716	668	367	190	176	27	893
Mari Hirvinen Finland	13	651 0.9×	550 0.8×	361 1.0×	236 1.2×	196 1.1×	19	878
Sari Pesonen Finland	16	734 1.0×	629 0.9×	448 1.2×	213 1.1×	206 1.2×	24	947
Minna Oksanen Finland	17	726 1.0×	666 1.0×	367 1.0×	210 1.1×	187 1.1×	24	884
Lotta Kangasniemi Finland	16	840 1.2×	685 1.0×	542 1.5×	145 0.8×	243 1.4×	24	1.0k
Mikko Siurala Finland	18	694 1.0×	846 1.3×	328 0.9×	300 1.6×	198 1.1×	26	986
Riikka Havunen Finland	19	753 1.1×	934 1.4×	375 1.0×	335 1.8×	223 1.3×	44	1.1k
Sari Pesonen Finland	20	659 0.9×	700 1.0×	537 1.5×	125 0.7×	219 1.2×	33	1.1k
Simona Bramante Finland	11	429 0.6×	403 0.6×	232 0.6×	152 0.8×	127 0.7×	12	601
Víctor Cervera-Carrascón Finland	18	513 0.7×	597 0.9×	249 0.7×	245 1.3×	167 0.9×	40	761
Assia L. Angelova Germany	14	582 0.8×	440 0.7×	250 0.7×	115 0.6×	104 0.6×	34	733

Countries citing papers authored by Timo Joensuu

Since Specialization

Citations

This map shows the geographic impact of Timo Joensuu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Joensuu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Joensuu more than expected).

Fields of papers citing papers by Timo Joensuu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Joensuu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Joensuu. The network helps show where Timo Joensuu may publish in the future.

Co-authorship network of co-authors of Timo Joensuu

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Joensuu. A scholar is included among the top collaborators of Timo Joensuu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Joensuu. Timo Joensuu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liikanen, Ilkka, Dafne C.A. Quixabeira, Otto Hemminki, et al.. (2022). Oncolytic adenovirus decreases the proportion of TIM-3⁺ subset of tumor-infiltrating CD8⁺ T cells with correlation to improved survival in patients with cancer. Journal for ImmunoTherapy of Cancer. 10(2). e003490–e003490. 18 indexed citations

Hemminki, Otto, Minna Oksanen, Ilkka Liikanen, et al.. (2018). Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy. Molecular Therapy — Oncolytics. 9. 41–50. 7 indexed citations

Liikanen, Ilkka, Anniina Koski, Raita Heiskanen, et al.. (2016). Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy. Molecular Therapy. 24(7). 1323–1332. 30 indexed citations

Bramante, Simona, Anniina Koski, Ilkka Liikanen, et al.. (2015). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology. 5(2). e1078057–e1078057. 36 indexed citations

Liikanen, Ilkka, Anniina Koski, Otto Hemminki, et al.. (2015). Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy. OncoImmunology. 4(3). e989771–e989771. 53 indexed citations

Hemminki, Otto, Suvi Parviainen, Juuso Juhila, et al.. (2015). Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy. Oncotarget. 6(6). 4467–4481. 69 indexed citations

Koski, Anniina, Simona Bramante, Anja Kipar, et al.. (2015). Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues. Molecular Therapy. 23(10). 1641–1652. 24 indexed citations

Liikanen, Ilkka, Juuso Juhila, Riku Turkki, et al.. (2015). Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus. Molecular Therapy. 24(1). 175–183. 25 indexed citations

Bramante, Simona, Johanna K. Kaufmann, Ville Veckman, et al.. (2015). Abstract B51: Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans. Cancer Immunology Research. 3(10_Supplement). B51–B51.

10.

Kanerva, Anna, Anniina Koski, Ilkka Liikanen, et al.. (2014). Case–Control Estimation of the Impact of Oncolytic Adenovirus on the Survival of Patients With Refractory Solid Tumors. Molecular Therapy. 23(2). 321–329. 12 indexed citations

11.

Kanerva, Anna, Petri Nokisalmi, Iulia Diaconu, et al.. (2013). Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF–Coding Oncolytic Adenovirus. Clinical Cancer Research. 19(10). 2734–2744. 144 indexed citations

12.

Hirvinen, Mari, Raita Heiskanen, Minna Oksanen, et al.. (2013). Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment. Journal of Translational Medicine. 11(1). 193–193. 15 indexed citations

13.

Liikanen, Ilkka, Laura Ahtiainen, Mari Hirvinen, et al.. (2013). Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients. Molecular Therapy. 21(6). 1212–1223. 139 indexed citations

14.

Koski, Anniina, Heidi Liljenbäck, Anne Roivainen, et al.. (2013). [ ¹⁸ F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer. Human Gene Therapy. 24(12). 1029–1041. 21 indexed citations

15.

Hemminki, Otto, Iulia Diaconu, Vincenzo Cerullo, et al.. (2012). Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer. Molecular Therapy. 20(9). 1821–1830. 62 indexed citations

16.

Raki, Mari, Merja Särkioja, Sophie Escutenaire, et al.. (2011). Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patients. The Journal of Gene Medicine. 13(5). 253–261. 28 indexed citations

17.

Koski, Anniina, Mari Raki, Petri Nokisalmi, et al.. (2011). Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer. Molecular Therapy. 20(1). 221–229. 28 indexed citations

18.

Escutenaire, Sophie, Vincenzo Cerullo, Iulia Diaconu, et al.. (2011). In vivoandin vitrodistribution of type 5 and fiber-modified oncolytic adenoviruses in human blood compartments. Annals of Medicine. 43(2). 151–163. 18 indexed citations

19.

Soini, Erkki, et al.. (2010). Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information. Annals of Oncology. 22(1). 215–223. 31 indexed citations

20.

Pesonen, Sari, Heikki Helin, Petri Nokisalmi, et al.. (2010). Oncolytic adenovirus treatment of a patient with refractory neuroblastoma. Acta Oncologica. 49(1). 120–122. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact